92 related articles for article (PubMed ID: 27372224)
1. Long-term observations of radiation-induced creatinine clearance reduction and renal parenchymal volume atrophy.
Inaba K; Okamoto H; Wakita A; Tsuchida K; Kashihara T; Kobayashi K; Harada K; Kitaguchi M; Sekii S; Umezawa R; Takahashi K; Murakami N; Ito Y; Igaki H; Uno T; Itami J
Radiother Oncol; 2016 Jul; 120(1):145-9. PubMed ID: 27372224
[TBL] [Abstract][Full Text] [Related]
2. Renal remodeling after abdominal radiation therapy: parenchymal and functional changes.
Tran LK; Maturen KE; Feng MU; Wizauer EJ; Watcharotone K; Parker RA; Ellis JH
AJR Am J Roentgenol; 2014 Aug; 203(2):W192-8. PubMed ID: 25055293
[TBL] [Abstract][Full Text] [Related]
3. Renal toxicity of adjuvant chemoradiotherapy with cisplatin in gastric cancer.
Welz S; Hehr T; Kollmannsberger C; Bokemeyer C; Belka C; Budach W
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1429-35. PubMed ID: 17692474
[TBL] [Abstract][Full Text] [Related]
4. Analysis of clinical and dosimetric factors associated with change in renal function in patients with gastrointestinal malignancies after chemoradiation to the abdomen.
May KS; Khushalani NI; Chandrasekhar R; Wilding GE; Iyer RV; Ma WW; Flaherty L; Russo RC; Fakih M; Kuvshinoff BW; Gibbs JF; Javle MM; Yang GY
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1193-8. PubMed ID: 19540051
[TBL] [Abstract][Full Text] [Related]
5. Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancer.
Jansen EP; Saunders MP; Boot H; Oppedijk V; Dubbelman R; Porritt B; Cats A; Stroom J; Valdés Olmos R; Bartelink H; Verheij M
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):781-5. PubMed ID: 17157445
[TBL] [Abstract][Full Text] [Related]
6. Comparison of changes in renal function with dosimetric parameters in gastric cancer patients treated with adjuvant chemoradiotherapy.
Kaydıhan N; Çepni K; Ergen ŞA; Şenocak MŞ; Öksüz DÇ
Jpn J Radiol; 2017 Dec; 35(12):733-739. PubMed ID: 29064001
[TBL] [Abstract][Full Text] [Related]
7. Change in creatinine clearance over time following upper abdominal irradiation: a dose-volume histogram multivariate analysis.
Diavolitsis VM; Rademaker A; Boyle J; Kang Z; Kiel K; Mulcahy M; Small W
Am J Clin Oncol; 2011 Feb; 34(1):53-7. PubMed ID: 20216303
[TBL] [Abstract][Full Text] [Related]
8. Renal atrophy secondary to chemoradiotherapy of abdominal malignancies.
Yang GY; May KS; Iyer RV; Chandrasekhar R; Wilding GE; McCloskey SA; Khushalani NI; Yendamuri SS; Gibbs JF; Fakih M; Thomas CR
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):539-46. PubMed ID: 20133075
[TBL] [Abstract][Full Text] [Related]
9. Comparing cystatin C changes as a measure of renal function before and after radiotherapy in patients with stomach cancer.
Rasouli HA; Moghadam MM; Tabatabaiefar M; Taslimi F; Sheybani KM; Alidoosti A; Ameri A; Fadavi P; Aref S
Acta Med Iran; 2012; 50(1):43-6. PubMed ID: 22267378
[TBL] [Abstract][Full Text] [Related]
10. Late renal function following whole abdominal irradiation.
Irwin C; Fyles A; Wong CS; Cheung CM; Zhu Y
Radiother Oncol; 1996 Mar; 38(3):257-61. PubMed ID: 8693108
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent changes in renal (1)H-/(23)Na MRI after adjuvant radiochemotherapy for gastric cancer.
Haneder S; Budjan JM; Schoenberg SO; Konstandin S; Schad LR; Hofheinz RD; Gramlich V; Wenz F; Lohr F; Boda-Heggemann J
Strahlenther Onkol; 2015 Apr; 191(4):356-64. PubMed ID: 25445156
[TBL] [Abstract][Full Text] [Related]
12. [Relationship of dose-volume histogram parameters and computed tomography grading of radiation-induced lung injury in patients with non-small cell lung cancer treated by three-dimensional conformal radiotherapy].
Xing J; Li JB; Yu JM; Lu J; Xu M; Fan TY; Shao Q; Guo SF
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):676-81. PubMed ID: 19173909
[TBL] [Abstract][Full Text] [Related]
13. Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy.
Bar-Ad V; Leiby B; Witek M; Xiao Y; Cui Y; Dai Y; Cao J; Axelrod R; Campling B; Both S; Werner-Wasik M
Am J Clin Oncol; 2014 Oct; 37(5):433-7. PubMed ID: 23388558
[TBL] [Abstract][Full Text] [Related]
14. Prediction of differential creatinine clearance in chronically obstructed kidneys by non-contrast helical computerized tomography.
Ng CF; Chan LW; Wong KT; Cheng CW; Yu SC; Wong WS
Int Braz J Urol; 2004; 30(2):102-7; discussion 108. PubMed ID: 15703088
[TBL] [Abstract][Full Text] [Related]
15. Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma.
Yamamoto T; Kadoya N; Takeda K; Matsushita H; Umezawa R; Sato K; Kubozono M; Ito K; Ishikawa Y; Kozumi M; Takahashi N; Katagiri Y; Onishi H; Jingu K
Radiat Oncol; 2016 May; 11():72. PubMed ID: 27229710
[TBL] [Abstract][Full Text] [Related]
16. Basal renal function reserve and mean kidney dose predict future radiation-induced kidney injury in stomach cancer patients.
Yavas G; Elsurer R; Yavas C; Ata O
Support Care Cancer; 2014 Feb; 22(2):445-51. PubMed ID: 24197055
[TBL] [Abstract][Full Text] [Related]
17. IMRT limits nephrotoxicity after chemoradiotherapy for gastric cancer.
Trip AK; Nijkamp J; van Tinteren H; Cats A; Boot H; Jansen EP; Verheij M
Radiother Oncol; 2014 Aug; 112(2):289-94. PubMed ID: 25241995
[TBL] [Abstract][Full Text] [Related]
18. Prediction of postoperative renal function by preoperative serum creatinine level and three-dimensional diagnostic image reconstruction in patients with renal cell carcinoma.
Tanaka N; Fujimoto K; Tani M; Yoshii M; Yoshida K; Hirao Y; Ozono S
Urology; 2004 Nov; 64(5):904-8. PubMed ID: 15533475
[TBL] [Abstract][Full Text] [Related]
19. Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship.
Barone R; Borson-Chazot F; Valkema R; Walrand S; Chauvin F; Gogou L; Kvols LK; Krenning EP; Jamar F; Pauwels S
J Nucl Med; 2005 Jan; 46 Suppl 1():99S-106S. PubMed ID: 15653658
[TBL] [Abstract][Full Text] [Related]
20. Radiation-induced dose-dependent changes of the spleen following postoperative chemoradiotherapy for gastric cancer.
Trip AK; Sikorska K; van Sandick JW; Heeg M; Cats A; Boot H; Jansen EP; Verheij M
Radiother Oncol; 2015 Aug; 116(2):239-44. PubMed ID: 26253953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
